Neurological Genetic Disorders tests in Dubai & UAE

Compare available Neurological Genetic Disorders tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetic Disorders test prices

Showing 1–15 of 21 matching tests.

Neurological Genetic Disorders diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4036 AARS1 Gene (CMT2N) Genetic Test This test evaluates the AARS1 gene for pathogenic variants associated with autosomal dominant axonal Charcot-Marie-Tooth disease type 2N (CMT2N).	Peripheral whole blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AARS1 gene variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number variants (CNV)"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling", "Three-generation pedigree chart required"] Indications ["Clinical suspicion of CMT2N", "Family history of CMT2N", "Need for definitive diagnosis of inherited neuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G60.0 Clinical summary This test evaluates the AARS1 gene for pathogenic variants associated with autosomal dominant axonal Charcot-Marie-Tooth disease type 2N (CMT2N).
TEST-4546 CACNA1S Gene Hypokalemic Periodic Paralysis Type 1 Genetic Test This genetic test identifies pathogenic variants in the CACNA1S gene, confirming the diagnosis of hypokalemic periodic paralysis type 1.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1S gene"] Parameters [] Preparation ["No specific fasting required", "Avoid strenuous exercise immediately before sample collection"] Indications ["Suspected diagnosis of hypokalemic periodic paralysis type 1", "Family history of hypokalemic periodic paralysis type 1", "Differential diagnosis of episodic weakness"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G72.3 Clinical summary This genetic test identifies pathogenic variants in the CACNA1S gene, confirming the diagnosis of hypokalemic periodic paralysis type 1.
TEST-5605 COL4A2 Gene Porencephaly Type 2 Genetic Test This genetic test identifies pathogenic variants in the COL4A2 gene, which are associated with familial porencephaly type 2 and cerebrovascular malformations.	Peripheral Whole Blood / Extracted DNA / FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL4A2 gene", "Copy Number Variants (CNVs) in COL4A2"] Parameters [] Preparation ["No fasting required", "Bring a list of current medications", "Pre-test genetic counselling session required"] Indications ["Suspected familial porencephaly type 2", "Diagnosis of cerebrovascular malformations", "Preconception counselling for at-risk families", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q04.6 Clinical summary This genetic test identifies pathogenic variants in the COL4A2 gene, which are associated with familial porencephaly type 2 and cerebrovascular malformations.
TEST-4658 CPLANE1 Gene (Joubert Syndrome Type 17) Genetic Test This test identifies pathogenic variants in the CPLANE1 gene associated with Joubert syndrome type 17.	Peripheral Whole Blood (EDTA) or FTA Card Blood Spot	21–28 Business Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CPLANE1 gene", "Single nucleotide variants (SNVs)", "Copy number variants (CNVs)"] Parameters [] Preparation ["Continue prescribed therapies unless advised otherwise by genetic counselor"] Indications ["Clinical suspicion of Joubert syndrome type 17", "Elective diagnostic purposes in stable patients"] Measurement technique Confirm with laboratory Codes LOINC: 48006-4 ICD-10: Q04.3, Z13.71, Z13.79 Clinical summary This test identifies pathogenic variants in the CPLANE1 gene associated with Joubert syndrome type 17.
TEST-5004 DNAL4 Gene (Mirror Movements Type 3) Genetic Test This test identifies pathogenic variants in the DNAL4 gene associated with congenital mirror movements type 3 (CMM3). It provides molecular confirmation for patients presenting wit...	Peripheral blood, FTA card, or extracted DNA	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DNAL4 gene"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history of mirror movements and neurological symptoms"] Indications ["Suspected congenital mirror movements type 3 (CMM3)", "Differential diagnosis of movement disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94825-7 ICD-10: Z13.5, R27.8 Clinical summary This test identifies pathogenic variants in the DNAL4 gene associated with congenital mirror movements type 3 (CMM3). It provides molecular confirmation for patients presenting with characteristic involuntary hand movements.
TEST-5376 DST Gene Neuropathy, Hereditary Sensory and Autonomic Type 6 (HSAN6) Genetic Test This genetic test evaluates the DST gene for pathogenic variants associated with Hereditary Sensory and Autonomic Neuropathy Type 6 (HSAN6). It provides a definitive molecular diag...	Peripheral whole blood (FTA card or venous)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DST gene", "Presence of mutations linked to HSAN6"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any bleeding disorders"] Indications ["Suspected diagnosis of Hereditary Sensory and Autonomic Neuropathy Type 6 (HSAN6)", "Family history of HSAN6", "Need for definitive molecular diagnosis for genetic counselling and family planning"] Measurement technique Confirm with laboratory Codes LOINC: 86238-5 ICD-10: G60.8, Z82.3, Z14.19 Clinical summary This genetic test evaluates the DST gene for pathogenic variants associated with Hereditary Sensory and Autonomic Neuropathy Type 6 (HSAN6). It provides a definitive molecular diagnosis for this rare neurological disorder.
TEST-3970 GBA2 Gene Cerebellar Ataxia with Spasticity Genetic Test This test identifies pathogenic variants in the GBA2 gene associated with autosomal recessive cerebellar ataxia with spasticity (SPG46/SCAR17).	Peripheral Whole Blood or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GBA2 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No specific fasting required.", "Inform the phlebotomist of any anticoagulant medication."] Indications ["Patients presenting with clinical features suggestive of autosomal recessive cerebellar ataxia with spasticity (SPG46/SCAR17)", "Family history of SPG46/SCAR17", "Diagnostic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 82327-0 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the GBA2 gene associated with autosomal recessive cerebellar ataxia with spasticity (SPG46/SCAR17).
TEST-4445 KCNC1 Gene Epilepsy, Progressive Myoclonic Type 7 Genetic Test This genetic test identifies pathogenic variants in the KCNC1 gene, confirming a diagnosis of progressive myoclonic epilepsy type 7 (EPM7).	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	14–21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KCNC1 gene sequence", "Pathogenic variants in KCNC1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected progressive myoclonic epilepsy type 7 (EPM7)", "Family history of EPM7", "Need for precise therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 93755-4 ICD-10: G40.4 Clinical summary This genetic test identifies pathogenic variants in the KCNC1 gene, confirming a diagnosis of progressive myoclonic epilepsy type 7 (EPM7).
TEST-5684 KCNJ10 Gene SESAME Syndrome Genetic Test This test sequences the KCNJ10 gene to identify pathogenic variants associated with SESAME syndrome.	Whole Blood (Peripheral)	3 to 4 Weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["KCNJ10 gene coding region", "Pathogenic variants (SNVs, indels)"] Parameters [] Preparation [] Indications ["Suspected SESAME syndrome", "Refractory seizures", "Sensorineural hearing loss", "Electrolyte imbalances"] Measurement technique Confirm with laboratory Codes LOINC: 82146-7 ICD-10: E87.6 Clinical summary This test sequences the KCNJ10 gene to identify pathogenic variants associated with SESAME syndrome.
TEST-3726 KIF7 Gene Acrocallosal Syndrome Genetic Test This genetic test identifies pathogenic mutations, including deletions and duplications, in the KIF7 gene associated with acrocallosal syndrome.	Whole Blood (EDTA), Buccal Swab, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the KIF7 gene", "Deletions/Duplications in the KIF7 gene"] Parameters [] Preparation [] Indications ["Suspected acrocallosal syndrome based on clinical presentation", "Family history of acrocallosal syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 60511-6 ICD-10: Q87.0 Clinical summary This genetic test identifies pathogenic mutations, including deletions and duplications, in the KIF7 gene associated with acrocallosal syndrome.
TEST-4716 NDUFAF1 Gene Leigh Syndrome Genetic Test This test analyzes the NDUFAF1 gene to detect pathogenic variants associated with Leigh syndrome, a severe neurological disorder.	Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFAF1 gene", "Coding region and splice sites of the NDUFAF1 gene"] Parameters [] Preparation ["Genetic counselling session required before sample collection", "Provide relevant family history"] Indications ["Clinical suspicion of mitochondrial disease", "Clinical suspicion of Leigh syndrome", "Carrier testing in at-risk families"] Measurement technique Confirm with laboratory Codes LOINC: 101484-1 ICD-10: G31.82 Clinical summary This test analyzes the NDUFAF1 gene to detect pathogenic variants associated with Leigh syndrome, a severe neurological disorder.
TEST-4725 NDUFS3 Gene (Leigh Syndrome) Genetic Test This genetic test identifies mutations in the NDUFS3 gene associated with Leigh syndrome.	Blood, Extracted DNA, FTA Card (one drop blood)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDUFS3 gene sequence", "Pathogenic variants in coding exons and flanking intronic regions"] Parameters [] Preparation [] Indications ["Suspected mitochondrial disease", "Children with developmental regression", "Ataxia", "Elevated lactate", "Family history of Leigh syndrome", "Carrier screening", "Prenatal risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G31.81, E88.49 Clinical summary This genetic test identifies mutations in the NDUFS3 gene associated with Leigh syndrome.
TEST-2638 PAFAH1B1 Gene Lissencephaly Type 1 (LIS1) Genetic Test This test identifies pathogenic variants in the PAFAH1B1 gene associated with classic lissencephaly type 1.	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PAFAH1B1 gene", "Single-nucleotide variants", "Copy-number variants"] Parameters [] Preparation ["No fasting or special preparation required"] Indications ["Children with unexplained severe developmental delay, infantile spasms, or brain imaging showing lissencephaly", "Expectant parents with a known family history"] Measurement technique Confirm with laboratory Codes LOINC: 89820-2 ICD-10: Q04.3 Clinical summary This test identifies pathogenic variants in the PAFAH1B1 gene associated with classic lissencephaly type 1.
TEST-5452 PLP1 Gene Pelizaeus-Merzbacher Disease Genetic Test This test evaluates the PLP1 gene for pathogenic variants associated with Pelizaeus-Merzbacher disease.	Peripheral Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PLP1 gene sequence", "Pathogenic variants (point mutations, deletions, duplications)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any bleeding disorders or latex allergies"] Indications ["Suspected Pelizaeus-Merzbacher disease", "Family history of PMD", "Neurological symptoms consistent with leukodystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 62138-2 ICD-10: G37.0 Clinical summary This test evaluates the PLP1 gene for pathogenic variants associated with Pelizaeus-Merzbacher disease.
TEST-4444 PRNP Gene Gerstmann-Sträussler Disease Genetic Test This test evaluates the PRNP gene for mutations associated with Gerstmann-Sträussler-Scheinker disease.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PRNP gene coding region", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected Gerstmann-Sträussler-Scheinker disease", "Family history of prion disorders", "Risk stratification for familial prion diseases"] Measurement technique Confirm with laboratory Codes LOINC: 21656-1 ICD-10: A81.82 Clinical summary This test evaluates the PRNP gene for mutations associated with Gerstmann-Sträussler-Scheinker disease.

Category overview

Neurological Genetic Disorders: overview

Understanding the broader hereditary factors affecting your central and peripheral nervous systems empowers you to manage chronic, overlapping symptoms and make highly informed health decisions. Representing an expansive offering within our advanced Genetics services, testing for Neurological Genetic Disorders utilizes comprehensive multi-gene panels to evaluate the complex pathways linked to hereditary spastic paraplegias, leukodystrophies, and familial seizure disorders. Utilizing cutting-edge genomic technology, this robust screening delivers the definitive clarity needed to diagnose complex neurological cases, safely guiding highly customized neurology oversight, proactive physical rehabilitation, and specialized genetic counseling. Consistently ranked among the top diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable reporting. Prioritize your lifelong neurological wellness—book your neurological genetic disorders testing in UAE, arrange a secure clinical sample transfer, or reach out to our dedicated medical genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.